chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A. fib c RVR, CHF, myocarditis. Diltiazem. Shipped to higher level of care. Sxs: SOB, CP
Tingling in left arm; Numbness in left arm; Enough to wake her up from sleep; Hurting left arm; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling in left arm), HYPOAESTHESIA (Numbness in left arm), SLEEP DISORDER (Enough to wake her up from sleep) and PAIN IN EXTREMITY (Hurting left arm) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Lot# 040A21A) for COVID-19 vaccination.     The patient's past medical history included Postmenopausal symptoms. Concurrent medical conditions included Hypertension (Under control), Latex allergy, Allergy to chemicals and Soap allergy. Concomitant products included OLMESARTAN, ESTRADIOL, MULTIPLUS, EPINEPHRINE (EPIPEN) and VITAMINS NOS (VIT B COMPLEXE [VITAMINS NOS]) for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 18-Mar-2021, the patient experienced PARAESTHESIA (Tingling in left arm), HYPOAESTHESIA (Numbness in left arm), SLEEP DISORDER (Enough to wake her up from sleep) and PAIN IN EXTREMITY (Hurting left arm). At the time of the report, PARAESTHESIA (Tingling in left arm), HYPOAESTHESIA (Numbness in left arm), SLEEP DISORDER (Enough to wake her up from sleep) and PAIN IN EXTREMITY (Hurting left arm) outcome was unknown.      No treatment related information has been reported.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Flu like symptoms, upper arm swelled at injection site, slightly disoriented, and then both hands went numb and stiffened this last part lasted about 40 minutes. Didn't feel good the next day pretty much just stayed in bed.
ZOSTAVAX administered on 5-21-14. On 6-5-14 the patient notified pharmacy of reaction - injection site was red and hot for first 2 day. It became swollen from elbow to fingers. We called prescriber on 6-6-14. We advised patient to see doctor. I called patient to follow up on 6-9-14. He took prednisone and was doing fine - reaction gone.
Child began complaining of bad headache, body tingling and taste buds were off. Mom stated he had a low-grade fever. Lasted 1 day. Mom did not obtain medical care for him.
Pain on the three joints I have had tendinitis due to sports injuries (left hip, left knee, left elbow). I had felt fine from after the shot at 10:30am that day (Thursday 5/6/21)  until that evening, where I did feel some soreness in those joints. I took two Alleve pills an hour prior to bedtime.  I woke up in pain at 2:00AM that night (5/7/21) on the said joints, about a level 6-7 out of 10.   By morning the pain had subsided a bit, but I was in pain walking for the next day (Friday) and today (Saturday).
didn't eat or drink for 4 days, constant out of control screaming, didn't sleep, minor convuls (if you can call any convuls minor), shook & shook;
Patient had been administered dose while the temperature excursion assessment was ongoing (possible temperature excursion); Patient had been administered dose while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patient had been administered dose while the temperature excursion assessment was ongoing (possible temperature excursion)) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient had been administered dose while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient had been administered dose while the temperature excursion assessment was ongoing (possible temperature excursion)) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient had been administered dose while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patient had been administered dose while the temperature excursion assessment was ongoing (possible temperature excursion)) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient had been administered dose while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  The reporter mentioned that the patient had been administered dose while the temperature excursion assessment was ongoing. No adverse reactions were reported by the patient.  No treatment information was provided by the reporter.
Father called and reported (R) arm at site of injection. Red, swollen, painful to touch, size silver dollar - referred to MD.
Vomiting, severe stomach and abdominal pain, severe and constant knee joint pain, rash at site of injection along with burning, irritation and bruising, loss of appetite, unusual tiredness and weakness.
Information has been received from a physician concerning a 6-month-old female who on 26-OCT-2006 was vaccinated PO with the first 2.0 mL dose of Rotateq. On 26-FEB-2007, the patient was vaccinated PO with the third 2.0 mL dose of Rotateq. On 26-FEB-2007, the patient developed severe diarrhea and vomiting. Unspecified medical attention was sought. On 28-FEB-2007, the patient recovered from the severe diarrhea and vomiting while on therapy. Additional information has been requested. 29-OCT-2009 This is in follow-up to report (s) previously submitted on 4/13/2007. Information has been received from a physician concerning a 6-month-old female who on 26-OCT2-2006 was vaccinated PO with the first 2.0 mL dose of rotavirus G1 G2 G3 G4 P1 reassortant vaccine live (human-bovine). On 26-FEB-2007, the patient developed severe diarrhea and vomiting. Unspecified medical attention was sought. On 28-FEB-2007, the patient recovered from the severe diarrhea and vomiting while on therapy. No further information is available.
red spot then it stated to feel Itchy; injection site area was smooth; red about 2 inch circular diameter around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (red spot then it stated to feel Itchy), INJECTION SITE REACTION (injection site area was smooth) and VACCINATION SITE ERYTHEMA (red about 2 inch circular diameter around the injection site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced RASH PRURITIC (red spot then it stated to feel Itchy), INJECTION SITE REACTION (injection site area was smooth) and VACCINATION SITE ERYTHEMA (red about 2 inch circular diameter around the injection site). At the time of the report, RASH PRURITIC (red spot then it stated to feel Itchy), INJECTION SITE REACTION (injection site area was smooth) and VACCINATION SITE ERYTHEMA (red about 2 inch circular diameter around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The relevant concomitant medications were also not provided. No treatment information was provided; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
09/14/2021 facial redness and swelling, itching rash, chills, body aches, cough took  OTC Benadryl  09/15/2021 03:30AM shortness of breath took pro air rescue inhaler   09/15/2021 05:00AM severe Left sided pain from head to  forehead to chin numbness and tingling   09/15/2021 08:00AM chills, fatigue, cough, general Malaise, body aches   09/06/2021 09:30AM numbness and tingling to bilateral upper and lower extremities
The day after, patient ran a 104F plus fever. His throat hurt, arms and legs hurt. This went on for 3 1/2 days.  This is the 3rd year he has gotten sick after the flu shot.  This can not be a coincidence.  No one else in the family catches this from him.  He is the only one who ends up sick.  He now seems to have reoccurring symptons every 6 weeks.  We administer Tylenol and Motrin.  That seems to keep the fever in track and I use a wet cold rag on his forehead.
fever, chills, cough, dizziness, upset stomach, site of inj sore, red, swollen;
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced injection site pain and tiredness. On an unknown date, the outcome of the injection site pain and tiredness were recovered/resolved. It was unknown if the reporter considered the injection site pain and tiredness to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient experienced pain at injection site but was not extreme. The patient might have felt a little pain but was not as noticeable. The patient was concerned about how long the event would remain. The patient denied to receive a call back and would contact the provider. The patient was disappointed as the answer was not provided by GlaxoSmithKline. For tolerance to next dose, refer case US2019AMR043108.
Around 8pm on date of administration, patient complained of low grade fever and general anxiety accompanied by uncontrolled movement/nervous twitching of one leg. Patient took alprazolam and BENADRYL which seemed to decrease anxiety symptoms.
Slight chills and headache for 6 hours, fever of 101.6 for 24 hours, fever of 99 for 24 hours.
This spontaneous report as received from a licensed nurse practitioner refers to multiple unspecified patients of unknown age and gender. On 01-OCT-2014 the patients were vaccinated with (Merck) VARIVAX (dosing details unknown). The reporter stated that she had a supported temperature excursion that affected (Merck) VARIVAX. Reporter stated that she presumed she had administered to multiple unspecified patients since the first excursion date, on 01-OCT-2014, but had no patient or product specific information to offer. No adverse effects were noted. Outcome of the temperature excursion of (Merck) VARIVAX was unknown. No product quality complaint was involved. This is one of the several cases received from the same reporter. Additional information has been requested.
Pt recvd vax & 10 hrs p/vax exp nausea, vomiting, diarrhea & nausea; nauseated for 4 days;
2 febrile seizures in DEC93; immunization 14MAR94 afebrile seizures p/that pt hospitalized for szs in APR94, behavior has been problem more whiny & balance is off, injured rt foot jumping;
Fatigue; Fever; Muscle aches; This is a spontaneous report from a contactable consumer (patient). A 79-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: E19267), via an unspecified route of administration in right arm on 17Feb2021 at 02:30 PM at single dose for COVID-19 immunisation.The patient's medical history included high BP, high cholesterol and diabetes. The patient was allergic to Mobic. It was reported that prior to vaccination, the patient was diagnosed with COVID-19 and the patient did not get tested for COVID-19, since the vaccination. The patient's concomitant medications included celecoxib (CELEBREX), metformin, allopurinol and pravastatin. On 18Feb2021 at 6:30 AM, the patient experienced fatigue, fever and muscle aches for 36 hours. The patient did not received any treatment. The outcome of the events was recovered.
patient had problem when missed humira for not getting prescription when ran out of medication.; Pain; Chills; Low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of UNEVALUABLE EVENT (patient had problem when missed humira for not getting prescription when ran out of medication.), PAIN (Pain), CHILLS (Chills) and PYREXIA (Low grade fever) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form On an unknown date, received second dose of mRNA-1273 (Spikevax) (Intramuscular) dosage was changed to 1 dosage form, third dose of mRNA-1273 (Spikevax) (Intramuscular) dosage was changed to 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) Solution for injection in pre-filled pen. and ADALIMUMAB (HUMIRA) (Subcutaneous) dosage was changed to Solution for injection in pre-filled pen. On an unknown date, the patient experienced UNEVALUABLE EVENT (patient had problem when missed humira for not getting prescription when ran out of medication.), PAIN (Pain), CHILLS (Chills) and PYREXIA (Low grade fever). At the time of the report, UNEVALUABLE EVENT (patient had problem when missed humira for not getting prescription when ran out of medication.) outcome was unknown and PAIN (Pain), CHILLS (Chills) and PYREXIA (Low grade fever) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: Low grade fever.         Concomitant product use was not provided by the reporter.  Action taken was reported as unknown for the co-suspect ADALIMUMAB (HUMIRA) with respect to all the events.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  Treatment information was not provided.  The reporter's causality for the event(s) of chills, low grade fever and pain with HUMIRA(ADALIMUMAB) was no reasonable possibility. The reporter's causality for the event(s) of patient had problem when missed humira for not getting prescription when ran out of medication was not provided.   This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.   Reporter did not allow further contact
Vaccine administered 4/15 experienced normal soreness in right arm. 4/17 started to experience a burning/tingling sensation near shoulder on right side. I was not sure if this was normal or not since I did not receive a vaccine information statement. I went back to clinic that administered vaccine 4/27. They were not able to tell me what was wrong. They stated they never saw anything like this before. They prescribed Meloxicam for pain and inflammation. As well as referred me to fill out this form and speak with the Department of Health. I spoke with them and I need a referral from my PCP to be seen. I called my PCP and I am waiting to hear back from them. Almost a month later I am still experiencing a burning/tingling sensation near my shoulder on the right side of my body.
This is a spontaneous report received from contactable other HCP. A 6-year-old male patient received the 2nd dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# FK5618), at the age of 6, in right arm, on Jan 6, 2022, at 14:15, single dose, for COVID-19 immunization. Medical history and concomitant medication not reported. Vaccination history included the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# FK5618), at the age of 5, in right arm, Dec 2021, single dose, for COVID-19 immunization. The patient experienced pyrexia (fever) and dizziness, onset Jan 7, 2022, at 03:00, with outcome of not recovered. Therapeutic measures were not taken as a result of pyrexia and dizziness. Additional information: No other vaccine in four weeks and no other medications in two weeks. No COVID-19 prior vaccination. No COVID-19 post vaccination. No follow-up attempts possible. No further information expected.
pt recvd vax 4NOV94 mom states that on 8NOV94 pt had fever of 103.2, vomited x 2, & had what was described as sz activity; stated whole body was shaking, eyes rolled back up in head, & teeth clinched lasting approx 1min; mom phoned ambulanc
low grade fever; chills; body aches; This is a spontaneous report from a contactable consume. This 23-year-old non-pregnant female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EWD179) via an unspecified route of administration in the left arm on 15May2021 at 10:00 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to vaccination the patient was not diagnosed with COVID-19 and had not received any other vaccines in the 4 weeks prior to the COVID vaccine. The patient had no concomitant medications. Prior to vaccination the patient received the first dose of BNT162B2 (lot number EW0169) on 24Apr2021 at 10:00 (at the age of 23-years-old) in the left arm for COVID-19 immunisation; and montelukast sodium (SINGULAIR) from an unknown date for an unknown indication and experienced drug allergy. On 15May2021 at 22:00 the patient experienced low-grade fever, chills and body aches. The events were reported as non-serious and did not require hospitalization. No treatment was received for the events. The clinical outcomes of low-grade fever, chills, and body aches were not recovered. It was also reported that since vaccination the patient had not been tested for COVID-19.  No follow-up attempts are needed. No further information is expected.
Monovalent Moderna vaccine administered to patient after Beyond Use Date. Moderna stored in fridge with 30-day BUD on 3/9/23. Dose drawn and administered on 3/27/23. There have been no reported adverse reactions to the dose.
Patient experienced mild flu-like symptoms on the evening of the day on which he received a flu shot. He had received flu shots in the past, but believes that this was the first time he had received High Dose.
Irregular period; started out light the first day; almost non-existent on day 2; then heavy from day 3 and on. I am now on day 5 and still very heavy to the point of clotting. I am normally very light on day 5 and period lasts about 6 days.
I started to notice significant hair loss about a week after my first dose of my Pfizer Covid 19 shot.  While I shampoo my hair and then combing it, I was losing a lot of head hair.  Normally, I do lose some hair during this process.   However, after my vaccine I noticed much more hair loss.  As of this date, I continue to lose more than normal head hair when shampooing.
This is a spontaneous report from a contactable nurse reporting for 2 patients, and from a contactable physician via Pfizer Customer Service. This is the 1st of 2 reports. A 73-year-old male patient of an unspecified ethnicity started to receive PREVNAR 13 (Lot # M56417, Expiry Date Jun2017) intramuscular at 0.5 ml, single in the left deltoid on 24Mar2016 13:06. The patient medical history was not reported. The patient's concomitant medications were not reported. No other vaccine were given on same date along with suspected vaccine. No other vaccinations within 4 weeks prior. The patient experienced afebrile cellulitis on 24Mar2016, late that evening. The event afebrile cellulitis required an emergency room or doctor visit on 25Mar2016 and he came with redness and swelling. No hospital stay. The patient stated it started the night of the vaccination and the next morning it was more significant. The patient was treated with KEFLEX 500mg and it has resolved. On an unspecified date the patient recovered from the events.
Received the 2nd shot. Developed chest pain and shortness of breath within 5 days. Had a coronary artery dissection and heart attack on 2/26/2021. Received the booster shot on November 3, 2021 (also Moderna). 2 weeks later developed mild chest pain, which has gotten increasing worse. Also developed increase heart rate when resting and elevated blood pressure (around 11/21/2021).
11/11/22 presents to ED for "dyspnea". PMHx of "paroxysmal AF and DM"
This spontaneous report as received from a licensed practical nurse refers to a 42 year old male patient who is a physician. The patient had no pertinent medical history, drug reactions/allergies and concomitant medications. On 08-MAR-2016, patient received accidentally an unspecified dose of GARDASIL 9 (lot # L013429, expiry date 21-JUL-2017) intradermally in error (incorrect route of drug administration). The patient was indicated to receive a tuberculin (PPD), or Mantoux tuberculin skin test. The error was made because both of the products have a brown flip-cap (product packaging confusion). Since 08-MAR-2016 the patient experienced injection site reactions and reports that his arm feels like it is on fire. On an unknown date in March 2016, the patient began to develop a raised welt, which measures approximately 2 inches x 1 inch and injection site indurated 1 cm x 11 mm. It was reported that the event appears like a positive PPD test, as a result of the patient's belief that he has a positive PPD test. On 10-MAR-2016 a QuantiFERON-TB Gold test was performed whose results were not provided. On an unspecified date chest X-Ray was also done whose results were not reported. It was reported no treatment was given to the events. The reporter states that injection site looks like DTAP. The reporter also states that injection site reactions with DTAP are not common. The outcome of tuberculin test positive was reported as unknown. The outcome of other events were reported to be not recovered. Product quality complaint (PQC) was not filed. Causality assessment was not provided. Additional information has been requested.
Irregular menses for 5 months now (as of 9/20/21). Menses were regular, every 28-30 days, until 4/24/21. Periods are now intermittently two weeks late (roughly 3/4 of menstrual cycles).  IUD had been in place for 5 years and is still in place. Menses are carefully tracked monthly.
Severe localized reaction from PNEUMOVAX evening of day vaccine given. Reported that her arm (left) knotted up, became rock hard and stiff, hurt to move and had shooting pains up and down arm. This lasted approx. 24 hrs knot then decreased followed by red "splotches" and a warm sensation no itching. This is decreasing after approx another 24 hours.
Measles like red itchy rash over all body but especially areas of sun contact such as tops of hands, arms and chest  after 7 days of anti histamine pill still itchy and now face swollen and red
Patient tested positive for COVID-19 at nursing home on 9/23, presented to ED for shortness of breath, admitted and currently undergoing inpatient treatment.
This spontaneous report as received from a licensed vocational nurse refers to an unspecified number of patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. On unknown dates, the patients were vaccinated with the improperly stored (15 hours in 34F) doses of GARDASIL 9 (lot # reported as L020190 with expiration date 13-APR-2017; dose and route of administration were not reported). No previous excursion and no adverse effects were reported. This is one of two reports received from the same reporter. Additional information has been requested.